Andries H Lesterhuis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andries H Lesterhuis has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Herman Meurs
Department of Molecular Pharmacology, Groningen Research Institute for Asthma and COPD, University of Groningen, Groningen, The Netherlands
1 shared publication - Johan Zaagsma
Department of Molecular Pharmacology, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands
1 shared publication - Marco van der Toorn
Laboratory of Allergology and Pulmonary Diseases, University Medical Center Groningen, Groningen, The Netherlands
1 shared publication - Reinoud Gosens
Department of Molecular Pharmacology, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands
1 shared publication - Riham Sami
Department of Molecular Pharmacology, University Centre for Pharmacy, University of Groningen, Groningen, The Netherlands
1 shared publication - Tonio Pera
Department of Molecular Pharmacology, University Centre for Pharmacy, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 29 April 2010
- Published by Springer Nature in Respiratory Research
- Vol. 11 (1) , 48
Cigarette smoke and lipopolysaccharide induce a proliferative airway smooth muscle phenotype
A major feature of chronic obstructive pulmonary disease (COPD) is airway remodelling, which includes an increased airway smooth muscle (ASM) mass. The mechanisms underlying ASM remodelling in COPD are currently unknown. We hypothesized that cigarette smoke (CS) and/or lipopolysaccharide (LPS), a major constituent of CS, organic dust and gram-negative bacteria, that may be involved in recurrent airway infections and exacerbations in COPD patients, would induce phenotype changes of ASM.
- 29 April 2010
- Published by Springer Nature in Respiratory Research
- Vol. 11 (1) , 48
Open AccessCigarette smoke and lipopolysaccharide induce a proliferative airway smooth muscle phenotype
A major feature of chronic obstructive pulmonary disease (COPD) is airway remodelling, which includes an increased airway smooth muscle (ASM) mass. The mechanisms underlying ASM remodelling in COPD are currently unknown. We hypothesized that cigarette smoke (CS) and/or lipopolysaccharide (LPS), a major constituent of CS, organic dust and gram-negative bacteria, that may be involved in recurrent airway infections and exacerbations in COPD patients, would induce phenotype changes of ASM.